RT Journal
A1 Steinbrook R
T1 Controlling hiv/aids: The obstacles and opportunities ahead
JF JAMA Internal Medicine
JO JAMA Internal Medicine
YR 2013
FD January 14
VO 173
IS 1
SP 11
OP 12
DO 10.1001/2013.jamainternmed.874
UL http://dx.doi.org/10.1001/2013.jamainternmed.874
AB 
Even without a vaccine, the primary reasons for optimism are the effectiveness of antiretroviral therapy in treating and preventing HIV infection and the increased availability of resources for programs in low- and middle-income nations. Deaths from AIDS-related causes peaked in the United States in 1995, and globally in 2005. At present, there are more people living with HIV than ever before, but many fewer new infections each year than earlier in the epidemic. Of the estimated 34.2 million people living with HIV worldwide in 2011, about 8 million had access to antiretroviral therapy, 20% more than in 2010.